Lei Hou

429 total citations
16 papers, 309 citations indexed

About

Lei Hou is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Lei Hou has authored 16 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Lei Hou's work include Virus-based gene therapy research (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer Research and Treatments (2 papers). Lei Hou is often cited by papers focused on Virus-based gene therapy research (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer Research and Treatments (2 papers). Lei Hou collaborates with scholars based in China and United States. Lei Hou's co-authors include Shangke Huang, Feng Lu, Xinhan Zhao, Meng Du, Minna Luo, Lifeng Liu, Jian Li, Peng Xia, Tianjie Qin and Shan Shao and has published in prestigious journals such as PLoS ONE, The Plant Cell and Scientific Reports.

In The Last Decade

Lei Hou

16 papers receiving 308 citations

Peers

Lei Hou
Comparison fields: 5 of 63
  • Molecular Biology 187
  • Oncology 112
  • Cancer Research 94
  • Immunology 39
  • Cellular and Molecular Neuroscience 27
Replace Sara Charmsaz with:
Sara Charmsaz Ireland
Susan Yeyeodu United States
Tao Qin China
Qiaowei He China
Dominique Arsenault Canada
Christopher S. Lyle United States
Tona Schnee United States
Ruowu Shen China
Iratxe Zuazo-Gaztelu United States
Evangelia Pantazaka Greece
Sara Charmsaz Ireland View profile →
Citations per field, relative to Lei Hou
Lei Hou · 1×
Citations per year, relative to Lei Hou
Lei Hou · 1×

Countries citing papers authored by Lei Hou

Since Specialization
Citations

This map shows the geographic impact of Lei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Hou more than expected).

Fields of papers citing papers by Lei Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Hou. The network helps show where Lei Hou may publish in the future.

Co-authorship network of co-authors of Lei Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Hou. A scholar is included among the top collaborators of Lei Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Hou. Lei Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
# Work Indexed citations
1 1
2 4
3
Stigmasterol Depresses the Proliferation and Facilitates the Apoptosis of Fibroblast-Like Synoviocytes via the PI3K/AKT Signaling Pathway in Collagen-Induced Arthritis Rats.
4
4 20
5 16
6 3
7 11
8 127
9 3
10 3
11 4
12 26
13 39
14 22
15 6
16 20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026